Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000070415-00-000032
Filing Date
2000-06-06
Accepted
2000-06-06 00:00:00
Documents
1
Period of Report
2000-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 - MAY 8, 2000 0001.txt 4 5716
  Complete submission text file 0000070415-00-000032.txt   8239
Mailing Address 9 WEST 57TH STREET STE 4107 NEW YORK NY 10019
Business Address 9 W 57TH ST STE 4170 NEW YORK NY 10019 2122309500
GP STRATEGIES CORP (Reporting) CIK: 0000070415 (see all company filings)

EIN.: 131926739 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8200 Services-Educational Services

Mailing Address 783 JERSEY AVENUE 783 JERSEY AVENUE NEW BRUNSWICK NJ 08901
Business Address 783 JERSEY AVE NEW BRUNSWICK NJ 08901 9082493250
INTERFERON SCIENCES INC (Subject) CIK: 0000351532 (see all company filings)

EIN.: 222313648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-10379 | Film No.: 650090
SIC: 2836 Biological Products, (No Diagnostic Substances)